Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries

Radiology

Volumn 255, Issue 3, 2010, Pages 988-1000

  Gerretsen, Suzanne C ^a   Le Maire, Thierry F ^b   Miller, Stephan ^c   Thurnher, Siegfried A ^d   Herborn, Christoph U ^e   Michaely, Henrik J ^f   Kramer, Harald ^g   Vanzulli, Angelo ^h   Vymazal, Josef ⁱ   Wasser, Martin N ^j   Ballarati, Claudio E M ^k   Kirchin, Miles A ^l   Pirovano, Gianpaolo ^l   Leiner, Tim ^a,m,n  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d St John of God Hospital   (Austria)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁱ Homolce Hosp   (Czech Republic)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k VALDUCE HOSPITAL   (Italy)

^l Bracco Imaging ^*  (United States)

^m MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DIZZINESS; DOUBLE BLIND PROCEDURE; DYSGEUSIA; EYE IRRITATION; FEMALE; HEAT SENSATION; HUMAN; HYPERHIDROSIS; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NUCLEAR MAGNETIC RESONANCE SCANNER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THORAX PAIN; THREE DIMENSIONAL IMAGING; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GADOLINIUM DTPA; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PELVIS; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 77952707562     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10090357     Document Type: Article

References (54)

1. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 2000;174(4):1127-1135. (Pubitemid 30180017)
2. Vavrik J, Rohrmoser GM, Madani B, Ersek M, Tscholakoff D, Bucek RA. Comparison of MR angiography versus digital subtraction angiography as a basis for planning treatment of lower limb occlusive disease. J Endovasc Ther 2004;11(3):294-301.
3. Lapeyre M, Kobeiter H, Desgranges P, Rahmouni A, Becquemin JP, Luciani A. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 2005;185(6):1641-1650.
4. Drescher R, Haller S, Köster O, von Rothenburg T, Titschert A. Standard-protocol moving-table magnetic resonance angiography for planning of interventional procedures in patients with peripheral vascular occlusive disease. Clin Imaging 2006;30(6):382-387.
5. Collins R, Burch J, Cranny G, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007;334(7606):1257-1265.
6. Thurnher SA, Capelastegui A, Del Olmo FH, et al. Safety and effectiveness of single- versus triple-dose gadodiamide injection- enhanced MR angiography of the abdomen: a phase III double-blind multicenter study. Radiology 2001;219(1):137-146.
7. Krause U, Kroencke T, Spielhaupter E, et al. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection. J Magn Reson Imaging 2005;21(4):449-454. (Pubitemid 40446441)
8. Schaefer PJ, Boudghene FP, Brambs HJ, et al. Abdominal and iliac arterial stenoses: comparative double-blinded randomized study of diagnostic accuracy of 3D MR angiography with gadodiamide or gadopentetate dimeglumine. Radiology 2006;238(3):827-840.
9. Schneider G, Ballarati C, Grazioli L, et al. Gadobenate dimeglumine-enhanced MR angiography: diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography. J Magn Reson Imaging 2007;26(4):1020-1032.
10. Wilson GJ, Hoogeveen RM, Willinek WA, Muthupillai R, Maki JH. Parallel imaging in MR angiography. Top Magn Reson Imaging 2004;15(3):169-185.
11. Zhang H, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson Imaging 2007;25(1):13-25.
12. de Vries M, Nijenhuis RJ, Hoogeveen RM, de Haan MW, van Engelshoven JM, Leiner T. Contrast-enhanced peripheral MR angiography using SENSE in multiple stations: feasibility study. J Magn Reson Imaging 2005;21(1):37-45. (Pubitemid 40041418)
13. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology 2002;225(1):43-52.
14. Boos M, Lentschig M, Scheffler K, Bongartz GM, Steinbrich W. Contrast-enhanced magnetic resonance angiography of peripheral vessels: different contrast agent applications and sequence strategies - a review. Invest Radiol 1998;33(9):538-546.
15. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188(2):586-592. (Pubitemid 46167763)
16. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243(1):148-157.
17. Kallen AJ, Jhung MA, Cheng S, et al. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Am J Kidney Dis 2008;51(6):966-975.
18. Abujudeh HH, Kaewlai R, Kagan A, et al. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. Radiology 2009;253(1):81-89.
19. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 2001;12(12):2838-2847. (Pubitemid 33115433)
20. Matsumae T, Abe Y, Murakami G, Ishihara M, Ueda K, Saito T. Determinants of arterial wall stiffness and peripheral artery occlusive disease in nondiabetic hemodialysis patients. Hypertens Res 2007;30(5):377-385. (Pubitemid 46958887)
21. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. [Published correction appears in Invest Radiol 2006;41(12):859.] Invest Radiol 2006;41(3):213-221. (Pubitemid 44406181)
22. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32(12):780-796.
23. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents. Invest Radiol 2006;41(3):222-228.
24. YrjänäSK, Vaara T, Karttunen A, Koivukangas J. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths. Invest Radiol 2008;43(4):267-275.
25. Bleicher AG, Kanal E. A serial dilution study of gadolinium-based MR imaging contrast agents. AJNR Am J Neuroradiol 2008;29(4):668-673. (Pubitemid 351571544)
26. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter cross-over comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005;234(2):399-408.
27. Pediconi F, Fraioli F, Catalano C, et al. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio. Radiol Med (Torino) 2003;106(1-2):87-93.
28. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17(6):694-702. (Pubitemid 36665874)
29. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003;227(1):261-269. (Pubitemid 36384208)
30. Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders [in German]. Helv Chir Acta 1954;21(5-6):499-533.
31. Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US - a meta-analysis. Radiology 2000;216(1):67-77.
32. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000;217(1):105-114. (Pubitemid 33097585)
33. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA 2001;285(10):1338-1345. (Pubitemid 32216150)
34. Thurnher S, Miller S, Schneider G, et al. Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial. AJR Am J Roentgenol 2007;189(5):1223-1237.
35. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York, NY: Wiley, 1981.
36. Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology 2003;226(3):798-811.
37. Bezooijen R, van den Bosch HC, Tielbeek AV, et al. Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography. Radiology 2004;231(1):263-271.
38. Bueltmann E, Erb G, Kirchin MA, Klose U, Naegele T. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced MR angiography of the supraaortic vessels at 3 Tesla. Invest Radiol 2008;43(10):695-702.
39. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies. Invest Radiol 2002;37(12):706-715.
40. Maravilla KR, Maldjian JA, Schmalfuss IM, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 2006; 240(2):389-400.
41. Rowley HA, Scialfa G, Gao PY, et al. Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual cross-over comparison of gadobenate dimeglumine versus gadodiamide. AJNR Am J Neuroradiol 2008;29(9):1684-1691.
42. Rumboldt Z, Rowley HA, Steinberg F, et al. Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla. J Magn Reson Imaging 2009;29(4):760-767.
43. Pediconi F, Catalano C, Occhiato R, et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 2005;237(1):45-56.
44. Pediconi F, Catalano C, Padula S, et al. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine. AJR Am J Roentgenol 2008;191(5):1339-1346.
45. Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging. Acad Radiol 2006;13(7):833-839.
46. Schneider G, Maas R, Schultze Kool L, et al. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Invest Radiol 2003;38(2):85-94.
47. Kroencke TJ, Wasser MN, Pattynama PM, et al. Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol 2002;179(6):1573-1582.
48. Wikström J, Wasser MN, Pattynama PM, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol 2003;38(8):504-515.
49. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography - multicenter comparative phase III study. Radiology 2005;236(1):71-78.
50. Goyen M, Edelman M, Perreault P, et al. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 2005;236(3):825-833.
51. Dietrich O, Raya JG, Reeder SB, Ingrisch M, Reiser MF, Schoenberg SO. Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging 2008;26(6):754-762.
52. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med 2005;54(3):748-754.
53. Berg F, Bangard C, Bovenschulte H, et al. Hybrid contrast-enhanced MR angiography of pelvic and lower extremity vasculature at 3.0 T: initial experience. Eur J Radiol 2009;70(1):170-176.
54. Leiner T, Kessels AG, Nelemans PJ, et al. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 2005;235(2):699-708.